https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-62004-08-05 00:00:002019-02-15 08:48:24Therapeutic cancer vaccines: using unique antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-06-01 / Int J Hyperthermia 2004 Jun;20(4):405-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-06-01 / Int J Hyperthermia 2004 Jun;20(4):405-192004-06-01 00:00:002019-02-15 09:17:50Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-912004-04-01 00:00:002004-04-01 00:00:00Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-01 / Pneumologie 2004 Apr;58(4):210-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-01 / Pneumologie 2004 Apr;58(4):210-62004-04-01 00:00:002004-04-01 00:00:00[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-532004-03-01 00:00:002019-02-15 08:48:24Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-702004-03-01 00:00:002004-03-01 00:00:00Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / BJU Int. 2004 Jan;93(1):36-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / BJU Int. 2004 Jan;93(1):36-412004-01-01 00:00:002019-02-15 10:00:39Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-92003-11-01 00:00:002003-11-01 00:00:00An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-09-01 / Int J Hyperthermia 2003 Sep-Oct;19(5):520-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-09-01 / Int J Hyperthermia 2003 Sep-Oct;19(5):520-332003-09-01 00:00:002019-02-15 08:48:25Thermal regulation of dendritic cell activation and migration from skin explants
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-09-01 / Int. Immunol. 2003 Sep;15(9):1053-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-09-01 / Int. Immunol. 2003 Sep;15(9):1053-612003-09-01 00:00:002019-02-15 09:17:51Fever-like temperature induces maturation of dendritic cells through induction of hsp90
